La recherche bibliographique avec lien direct vers la publication est marquée séparément. Un PMID ou DOI ne sera pas attribué aux 114 enregistrements en attente d’une correspondance. La vérification du lien source ne constitue pas une vérification de l’interprétation clinique. Détails de la méthode.

  1. Baur JA, Sinclair DA. (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews Drug Discovery, 5(6), 493–506. PubMed · PMID 16732220
    DOI : 10.1038/nrd2060

    Contenus utilisant cette ressource : resvératrol

  2. Bhatt, M. et al. (1999). Piracetam in myoclonus. Cochrane Database of Systematic Reviews. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Piracétam

  3. Deijen JB, Orlebeke JF. (1994). Effect of tyrosine on cognitive function and blood pressure under stress. Brain Research Bulletin, 33(3), 319–323. PubMed · PMID 8293316
    DOI : 10.1016/0361-9230(94)90200-3

    Contenus utilisant cette ressource : L-Tyrosine Performance cérébrale des athlètes : viser le pic physique et mental ensemble

  4. Waegemans, T. et al. (2002). Clinical efficacy of piracetam in cognitive impairment: a meta-analysis. Dementia and Geriatric Cognitive Disorders, 13(4), 217–224. PubMed · PMID 12006732
    DOI : 10.1159/000057700

    Contenus utilisant cette ressource : Piracétam

  5. Llewellyn DJ, et al. (2010). Vitamin D and risk of cognitive decline in elderly persons. Archives of Internal Medicine, 170(13), 1135–1141. PubMed · PMID 20625021
    DOI : 10.1001/archinternmed.2010.173

    Contenus utilisant cette ressource : Vitamine D3

  6. Bhagavan, H.N., Chopra, R.K. (2006). Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Research, 40(5), 445–453. PubMed · PMID 16551570
    DOI : 10.1080/10715760600617843

    Contenus utilisant cette ressource : Coenzyme Q10

  7. Eyles DW, et al. (2013). Vitamin D effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology, 34(1), 47–64. PubMed · PMID 22796576
    DOI : 10.1016/j.yfrne.2012.07.001

    Contenus utilisant cette ressource : Vitamine D3

  8. Canal N, et al. (1991). Effect of L-alpha-glyceryl-phosphorylcholine on amnesia caused by scopolamine. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 29(3), 103–107. PubMed · PMID 2071257

    Contenus utilisant cette ressource : Alpha-GPC

  9. Giesbrecht, T. et al. (2010). The combination of L-Theanine and caffeine improves cognitive performance and increases subjective alertness. Nutritional Neuroscience, 13(6), 283–290. PubMed · PMID 21040626
    DOI : 10.1179/147683010X12611460764840

    Contenus utilisant cette ressource : Caféine et L-Théanine : le duo nootropique le plus éprouvé

  10. Geng J, et al. (2010). Ginseng for cognition. Cochrane Database of Systematic Reviews, (12), CD007769. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Panax Ginseng

  11. Hausenblas HA, et al. (2013). Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. Journal of Integrative Medicine, 11(6), 377–383. PubMed · PMID 24299602
    DOI : 10.3736/jintegrmed2013056

    Contenus utilisant cette ressource : Extrait de Safran

  12. Linde K, et al. (2008). St John's wort for major depression. Cochrane Database of Systematic Reviews. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Millepertuis

  13. Birdsall TC. (1998). 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Alternative Medicine Review, 3(4), 271–280. PubMed · PMID 9727088

    Contenus utilisant cette ressource : 5-HTP

  14. Chandrasekhar K, Kapoor J, Anishetty S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262. PubMed · PMID 23439798
    DOI : 10.4103/0253-7176.106022

    Contenus utilisant cette ressource : ashwagandha

  15. Ferracioli-Oda E, Qawasmi A, Bloch MH. (2013). Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS ONE, 8(5), e63773. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : mélatonine

  16. Brondino N, et al. (2013). A systematic review and meta-analysis of Ginkgo biloba in neuropsychiatric disorders: from ancient tradition to modern-day medicine. Evidence-Based Complementary and Alternative Medicine, 2013, 915691. PubMed · PMID 23781271
    DOI : 10.1155/2013/915691

    Contenus utilisant cette ressource : Ginkgo Biloba

  17. Boyle NB, et al. (2017). The effects of magnesium supplementation on subjective anxiety and stress. Nutrients, 9(5), 429. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Suppléments naturels pour la dépression et l'anxiété : un guide basé sur des preuves

  18. Stough C, et al. (2001). The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology, 156(4), 481–484. PubMed · PMID 11498727
    DOI : 10.1007/s002130100815

    Contenus utilisant cette ressource : Bacopa Monnieri

  19. McEwen BS, Milner TA. (2007). Hippocampal formation: shedding light on the influence of sex and stress on the brain. Brain Research Reviews, 55(2), 343–355. PubMed · PMID 17395265
    DOI : 10.1016/j.brainresrev.2007.02.006

    Contenus utilisant cette ressource : Nootropiques pour les femmes : cycle hormonal et performance cognitive

  20. Stites T, et al. (2006). Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. Journal of Nutrition, 136(2), 390–396. PubMed · PMID 16424117
    DOI : 10.1093/jn/136.2.390

    Contenus utilisant cette ressource : PQQ (Pyrroloquinoline Quinone)

  21. Volkow ND, et al. (2009). Effects of modafinil on dopamine and dopamine transporters in the male human brain. JAMA, 301(11), 1148–1154. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : modafinil

  22. El Idrissi A, Trenkner E. (2004). Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochemical Research, 29(1), 189–197. PubMed · PMID 14992278
    DOI : 10.1023/b:where.0000010448.17740.6e

    Contenus utilisant cette ressource : taureau

  23. Calabrese C, et al. (2008). Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. Journal of Alternative and Complementary Medicine, 14(6), 707–713. PubMed · PMID 18611150
    DOI : 10.1089/acm.2008.0018

    Contenus utilisant cette ressource : Bacopa Monnieri

  24. Noorbala AA, Akhondzadeh S, et al. (2005). Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. Journal of Ethnopharmacology, 97(2), 281–284. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Extrait de Safran

  25. Grant JE, et al. (2009). N-acetyl cysteine, a glutamate-modulating agent, in the treatment of trichotillomania. Archives of General Psychiatry, 66(7), 756–763. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  26. Gohil, K.J., Patel, J.A., Gajjar, A.K. (2010). Pharmacological review on Centella asiatica: A potential herbal cure-all. Indian Journal of Pharmaceutical Sciences, 72(5), 546–556. PubMed · PMID 21694984
    DOI : 10.4103/0250-474X.78519

    Contenus utilisant cette ressource : Centella asiatica (Gotu Kola)

  27. Misra HS, et al. (2012). Pyrroloquinoline-quinone and its versatile roles in biological processes. Journal of Biosciences, 37(2), 313–325. PubMed · PMID 22581337
    DOI : 10.1007/s12038-012-9195-5

    Contenus utilisant cette ressource : PQQ (Pyrroloquinoline Quinone)

  28. Le Bars PL, et al. (1997). A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA, 278(16), 1327–1332. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Ginkgo Biloba

  29. Darbinyan V, et al. (2000). Rhodiola rosea in stress induced fatigue - a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine, 7(5), 365–371. PubMed · PMID 11081987
    DOI : 10.1016/S0944-7113(00)80055-0

    Contenus utilisant cette ressource : rhodiola rosea

  30. Parnetti L, et al. (2007). Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation? Journal of the Neurological Sciences, 257(1-2), 264–269. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Alpha-GPC

  31. Ames BN, et al. (2002). Delaying the mitochondrial decay of aging with acetylcarnitine. Annals of the New York Academy of Sciences, 959, 128–132. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  32. Awad R, et al. (2007). Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties. Phytomedicine. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Mélisse (Mélisse citronnelle)

  33. Slutsky I, et al. (2010). Enhancement of learning and memory by elevating brain magnesium. Neuron, 65(2), 165–177. PubMed · PMID 20152124
    DOI : 10.1016/j.neuron.2009.12.026

    Contenus utilisant cette ressource : Mg L-Thréonate Neuroplasticité : comment le cerveau se reconfigure-t-il ? Commencer avec les nootropiques : Le guide essentiel pour débutants Vitamines et minéraux essentiels pour le cerveau : le coût cognitif de la carence

  34. Lyon MR, et al. (2011). The effects of L-Theanine (Suntheanine) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD). Alternative Medicine Review, 16(4), 348–354. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : L-Théanine

  35. Alvarez-Sabín J, Román GC. (2013). The role of citicoline in neuroprotection and neurorepair in ischemic stroke. Brain Sciences, 3(3), 1395–1414. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : CDP-Choline

  36. Beal MF. (2004). Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases. Journal of Bioenergetics and Biomembranes, 36(4), 381–386. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Mitochondries et énergie cérébrale : l'origine de la fatigue cognitive

  37. Giurgea, C. (1972). Pharmacology of integrative activity of the brain. Actualités pharmacologiques, 25, 115–156. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Piracétam

  38. Bhattacharya, S.K. et al. (1993). Pramiracetam (CI-879) attenuates learned helplessness in rats. Pharmacology Biochemistry and Behavior, 45(4), 915–920. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : pramiracétam

  39. Winblad B. (2005). Piracetam: A review of pharmacological properties and clinical uses. CNS Drug Reviews, 11(2), 169–182. PubMed · PMID 16007238
    DOI : 10.1111/j.1527-3458.2005.tb00268.x

    Contenus utilisant cette ressource : Piles nootropiques : 5 combinaisons prouvées

  40. Sapolsky RM. (1996). Why stress is bad for your brain. Science, 273(5276), 749–750. PubMed · PMID 8701325
    DOI : 10.1126/science.273.5276.749

    Contenus utilisant cette ressource : Stress chronique et cerveau : l'effet du cortisol sur les performances cognitives

  41. Kongkeaw C, et al. (2014). Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri. Journal of Ethnopharmacology, 151(1), 528–535. PubMed · PMID 24252493
    DOI : 10.1016/j.jep.2013.11.008

    Contenus utilisant cette ressource : Commencer avec les nootropiques : Le guide essentiel pour débutants

  42. Roodenrys S, et al. (2002). Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology, 27(2), 279–281. PubMed · PMID 12093601
    DOI : 10.1016/S0893-133X(01)00419-5

    Contenus utilisant cette ressource : Bacopa Monnieri

  43. Müller, W.E. et al. (1997). Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain. Biochemical Pharmacology, 53(2), 135–140. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Piracétam

  44. Yoshino M, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229. PubMed · PMID 33888596
    DOI : 10.1126/science.abe9985

    Contenus utilisant cette ressource : NMN

  45. Lu B, Nagappan G, Lu Y. (2014). BDNF and synaptic plasticity, cognitive function, and dysfunction. Handbook of Experimental Pharmacology, 220, 223–250. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Neuroplasticité : comment le cerveau se reconfigure-t-il ?

  46. Hausenblas HA, et al. (2013). Saffron (Crocus sativus L.) and major depressive disorder: A meta-analysis of randomized clinical trials. Journal of Integrative Medicine, 11(6), 377–383. PubMed · PMID 24299602
    DOI : 10.3736/jintegrmed2013056

    Contenus utilisant cette ressource : Suppléments naturels pour la dépression et l'anxiété : un guide basé sur des preuves

  47. Mori K, et al. (2009). Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research, 23(3), 367–372. PubMed · PMID 18844328
    DOI : 10.1002/ptr.2634

    Contenus utilisant cette ressource : Crinière de Lion

  48. Salehi, B. et al. (2019). The therapeutic potential of apigenin. International Journal of Molecular Sciences, 20(6), 1305. (Genel derlemedir; spesifik mekanizma iddiaları için orijinal çalışmalar incelenmelidir.) Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Apigénine

  49. Owen GN, et al. (2008). The combined effects of L-Theanine and caffeine on cognitive performance and mood. Nutritional Neuroscience, 11(4), 193–198. PubMed · PMID 18681988
    DOI : 10.1179/147683008X301513

    Contenus utilisant cette ressource : L-Théanine Piles nootropiques : 5 combinaisons prouvées

  50. Kato-Kataoka A, et al. (2010). Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints. Journal of Clinical Biochemistry and Nutrition, 47(3), 246–255. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Phosphatidylsérine

  51. Jongkees BJ, et al. (2015). Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands-A review. Journal of Psychiatric Research, 70, 50–57. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : N-Acétyl L-Tyrosine

  52. Morgan, R.E. (2013). Nootropics and cognitive enhancement: a review of dosing, cycling and tolerance mechanisms. Journal of Psychopharmacology, 27(6), 555–563. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Cyclage des nootropiques : comment éviter la tolérance ?

  53. Reay JL, Kennedy DO, Scholey AB. (2005). Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. Journal of Psychopharmacology, 19(4), 357–365. PubMed · PMID 15982990
    DOI : 10.1177/0269881105053286

    Contenus utilisant cette ressource : Panax Ginseng

  54. Jongkees BJ, et al. (2015). Effect of tyrosine supplementation on clinical and healthy populations under stress and cognitive demands. Journal of Psychiatric Research, 70, 50–57. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : L-Tyrosine

  55. Talbott SM, et al. (2013). Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. Journal of the International Society of Sports Nutrition, 10, 28. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Tongkat Ali

  56. Malykh AG & Sadaie MR (2010). Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs, 70(3), 287–312. PubMed · PMID 20166767
    DOI : 10.2165/11319230-000000000-00000

    Contenus utilisant cette ressource : Phénylpiracétam

  57. Ferris SH, et al. (1977). Senile dementia: treatment with deanol. Journal of the American Geriatrics Society, 25(6), 241–244. PubMed · PMID 864168
    DOI : 10.1111/j.1532-5415.1977.tb00407.x

    Contenus utilisant cette ressource : DMAE

  58. Zhang C, et al. (2022). A Magtein®, Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults. Nutrients, 14(24), 5235. PubMed · PMID 36558392
    DOI : 10.3390/nu14245235

    Contenus utilisant cette ressource : Mg L-Thréonate

  59. Bizot JC, et al. (2005). Methylphenidate reduces some forms of impulsivity in rats and improves performance in a five-choice serial reaction time task. Psychopharmacology, 176(3–4), 376–385. [Sulbutiamin karşılaştırmalı referans] Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Sulbutiamine

  60. Zhu X, et al. (2014). Neuroprotective effect of berberine against hippocampus neuronal apoptosis in rat model. Phytomedicine. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Berbérine

  61. Storch, A. et al. (2007). Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Archives of Neurology, 64(7), 938–944. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Coenzyme Q10

  62. Magnusson I, et al. (1989). N-acetyl-L-tyrosine and the bioavailability of tyrosine. Journal of Parenteral and Enteral Nutrition, 13(4), 423–425. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : N-Acétyl L-Tyrosine

  63. Samokhvalov AV, et al. (2013). Phenibut dependence. BMJ Case Reports. PubMed · PMID 23391959
    DOI : 10.1136/bcr-2012-008381

    Contenus utilisant cette ressource : phénibut

  64. Calder PC (2016). Docosahexaenoic acid. Annals of Nutrition and Metabolism, 69(Suppl 1), 7–21. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  65. Kongkeaw C, et al. (2014). Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. Journal of Ethnopharmacology, 151(1), 528–535. PubMed · PMID 24252493
    DOI : 10.1016/j.jep.2013.11.008

    Contenus utilisant cette ressource : Bacopa Monnieri

  66. Dean O, et al. (2011). N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. Journal of Psychiatry & Neuroscience, 36(2), 78–86. PubMed · PMID 21118657
    DOI : 10.1503/jpn.100057

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  67. Cox KHM, et al. (2015). Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. Journal of Psychopharmacology, 29(5), 642–651. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : curcumine

  68. Nakano M, et al. (2012). Effect of pyrroloquinoline quinone (PQQ) on mental status of middle-aged and elderly persons. Food Style 21, 16(7), 281–287. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : PQQ (Pyrroloquinoline Quinone)

  69. Spagnoli A, et al. (1991). Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology, 41(11), 1726–1732. PubMed · PMID 1944900
    DOI : 10.1212/wnl.41.11.1726

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  70. Mori K, et al. (2009). Improving effects of Hericium erinaceus on mild cognitive impairment. Phytotherapy Research, 23(3), 367–372. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Neuroplasticité : comment le cerveau se reconfigure-t-il ? Commencer avec les nootropiques : Le guide essentiel pour débutants

  71. Weinmann S, et al. (2010). Effects of Ginkgo biloba in dementia. BMC Geriatrics, 10, 14. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Ginkgo Biloba

  72. Zhang H, et al. (2010). Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism, 59(2), 285–292. PubMed · PMID 19800084
    DOI : 10.1016/j.metabol.2009.07.029

    Contenus utilisant cette ressource : Berbérine

  73. Katzenschlager R, et al. (2004). Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. Journal of Neurology, Neurosurgery & Psychiatry, 75(12), 1672–1677. PubMed · PMID 15548480
    DOI : 10.1136/jnnp.2003.028761

    Contenus utilisant cette ressource : Mucuna Pruriens

  74. Bhatt JK, et al. (2012). Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutrition Research, 32(7), 537–541. PubMed · PMID 22901562
    DOI : 10.1016/j.nutres.2012.06.003

    Contenus utilisant cette ressource : Cerveau anti-âge : Protocole nootropique anti-âge

  75. Rae C, et al. (2003). Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. Proceedings of the Royal Society B: Biological Sciences, 270(1529), 2147–2150. PubMed · PMID 14561278
    DOI : 10.1098/rspb.2003.2492

    Contenus utilisant cette ressource : Créatine

  76. Watanabe A, et al. (2002). Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neuroscience Research, 42(4), 279–285. PubMed · PMID 11985880
    DOI : 10.1016/s0168-0102(02)00007-x

    Contenus utilisant cette ressource : Créatine

  77. Lampariello LR, et al. (2012). The magic velvet bean of Mucuna pruriens. Journal of Traditional and Complementary Medicine, 2(4), 331–339. PubMed · PMID 24716148
    DOI : 10.1016/s2225-4110(16)30119-5

    Contenus utilisant cette ressource : Motivation avec le système dopaminergique et les nootropiques

  78. Cases J, et al. (2011). Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Mediterranean Journal of Nutrition and Metabolism, 4(3), 211–218. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Mélisse (Mélisse citronnelle)

  79. Fisman M, et al. (1981). Double blind trial of 2-dimethylaminoethanol in Alzheimer's disease. Canadian Journal of Psychiatry, 26(7), 482–484. PubMed · PMID 7020434
    DOI : 10.1176/ajp.138.7.970

    Contenus utilisant cette ressource : DMAE

  80. Oliver JM, et al. (2016). Effect of docosahexaenoic acid on a biomarker of head trauma in American football. Medicine and Science in Sports and Exercise, 48(6), 974–982. PubMed · PMID 26765633
    DOI : 10.1249/MSS.0000000000000875

    Contenus utilisant cette ressource : Performance cérébrale des athlètes : viser le pic physique et mental ensemble

  81. Auld F, et al. (2017). Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Medicine Reviews, 34, 10–22. PubMed · PMID 28648359
    DOI : 10.1016/j.smrv.2016.06.005

    Contenus utilisant cette ressource : mélatonine

  82. Barth C, et al. (2015). Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Frontiers in Neuroscience, 9, 37. PubMed · PMID 25750611
    DOI : 10.3389/fnins.2015.00037

    Contenus utilisant cette ressource : Nootropiques pour les femmes : cycle hormonal et performance cognitive

  83. Liao B, et al. (2021). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners. Journal of the International Society of Sports Nutrition, 18(1), 54. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : NMN

  84. Glade MJ, Smith K. (2015). Phosphatidylserine and the human brain. Nutrition, 31(6), 781–786. PubMed · PMID 25933483
    DOI : 10.1016/j.nut.2014.10.014

    Contenus utilisant cette ressource : Phosphatidylsérine

  85. Haskell, C.F. et al. (2008). The effects of L-Theanine, caffeine and their combination on cognition and mood. Biological Psychology, 77(2), 113–122. PubMed · PMID 18006208
    DOI : 10.1016/j.biopsycho.2007.09.008

    Contenus utilisant cette ressource : Caféine et L-Théanine : le duo nootropique le plus éprouvé

  86. Di Stefano G, et al. (2000). Acetyl-L-carnitine in painful peripheral neuropathy: a randomized, double-blind, placebo-controlled trial. CNS Drugs, 14(5), 377–387. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  87. Cansev M, Wurtman RJ. (2007). Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience, 148(2), 421–431. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Monophosphate d'uridine

  88. Scholey A, et al. (2010). Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology, 212(3), 345–356. PubMed · PMID 20676609
    DOI : 10.1007/s00213-010-1964-y

    Contenus utilisant cette ressource : Panax Ginseng

  89. McEwen BS. (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiological Reviews, 87(3), 873–904. PubMed · PMID 17615391
    DOI : 10.1152/physrev.00041.2006

    Contenus utilisant cette ressource : Stress chronique et cerveau : l'effet du cortisol sur les performances cognitives

  90. Pandit S, et al. (2016). Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia, 48(5), 570–575. PubMed · PMID 26395129
    DOI : 10.1111/and.12482

    Contenus utilisant cette ressource : shilajit

  91. Yurko-Mauro K, et al. (2010). Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer's & Dementia, 6(6), 456–464. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  92. Fioravanti M, Buckley AE. (2006). Citicoline (Cognizin) in the treatment of cognitive impairment. Clinical Interventions in Aging, 1(3), 247–251. PubMed · PMID 18046877
    DOI : 10.2147/ciia.2006.1.3.247

    Contenus utilisant cette ressource : CDP-Choline

  93. Gouliaev, A.H., Senning, A. (1994). Piracetam and other structurally related nootropics. Brain Research Reviews, 19(2), 180–222. PubMed · PMID 8061686
    DOI : 10.1016/0165-0173(94)90011-6

    Contenus utilisant cette ressource : Oxiracétam pramiracétam

  94. Bellar D, et al. (2015). The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength. Journal of the International Society of Sports Nutrition, 12, 42. PubMed · PMID 26582972
    DOI : 10.1186/s12970-015-0103-x

    Contenus utilisant cette ressource : Alpha-GPC

  95. Nakano M, et al. (2012). Effect of PQQ on mental status of middle-aged and elderly persons. Food Style 21, 16(7). Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Mitochondries et énergie cérébrale : l'origine de la fatigue cognitive

  96. Voss MW, et al. (2013). Bridging animal and human models of exercise-induced brain plasticity. Trends in Cognitive Sciences, 17(10), 525–544. PubMed · PMID 24029446
    DOI : 10.1016/j.tics.2013.08.001

    Contenus utilisant cette ressource : Neuroplasticité : comment le cerveau se reconfigure-t-il ?

  97. Liu G, et al. (2016). Efficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults. Journal of Alzheimer's Disease, 49(4), 971–990. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Mg L-Thréonate

  98. Lagouge M, et al. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell, 127(6), 1109–1122. PubMed · PMID 17112576
    DOI : 10.1016/j.cell.2006.11.013

    Contenus utilisant cette ressource : resvératrol

  99. Dávalos A, et al. (2012). Citicoline in the treatment of acute ischaemic stroke: the ICTUS trial. The Lancet, 380(9839), 349–357. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : CDP-Choline

  100. Shuid AN, et al. (2011). Eurycoma longifolia increases testosterone level and bone structure in male osteoporotic rats. Evidence-Based Complementary and Alternative Medicine. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Tongkat Ali

  101. Sun QQ, et al. (1999). Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students. Zhongguo Yao Li Xue Bao, 20(7), 601–603. PubMed · PMID 10678121

    Contenus utilisant cette ressource : Huperzine A

  102. Suliman NA, et al. (2016). Establishing natural nootropics: recent molecular enhancement influenced by natural nootropic. Evidence-Based Complementary and Alternative Medicine, 2016, 4391375. PubMed · PMID 27656235
    DOI : 10.1155/2016/4391375

    Contenus utilisant cette ressource : Commencer avec les nootropiques : Le guide essentiel pour débutants

  103. Manyam BV, et al. (2004). Nongenotoxic and noncytotoxic effects of the anti-Parkinson drug HP-200 (Mucuna pruriens) - a neurobiological study. Phytotherapy Research, 18(9), 706–712. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Mucuna Pruriens

  104. Henkel RR, et al. (2014). Tongkat Ali as a potential herbal supplement for physically active male and female seniors. Phytotherapy Research, 28(4), 544–550. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Tongkat Ali

  105. Lopresti AL, Drummond PD. (2014). Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Human Psychopharmacology, 29(6), 517–527. PubMed · PMID 25384672
    DOI : 10.1002/hup.2434

    Contenus utilisant cette ressource : Extrait de Safran

  106. Ritsner MS, et al. (2011). L-Theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder. Journal of Clinical Psychiatry, 72(1), 34–42. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : L-Théanine

  107. Irie J, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal, 67(2), 153–160. PubMed · PMID 31685720
    DOI : 10.1507/endocrj.EJ19-0313

    Contenus utilisant cette ressource : NMN

  108. Sarter, M. et al. (2009). Phasic acetylcholine release and the volume transmission hypothesis. Trends in Neurosciences, 32(3), 185–195. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Cyclage des nootropiques : comment éviter la tolérance ?

  109. Facchinetti F, et al. (1991). Oral magnesium successfully relieves premenstrual mood changes. Obstetrics and Gynecology, 78(2), 177–181. PubMed · PMID 2067759

    Contenus utilisant cette ressource : Nootropiques pour les femmes : cycle hormonal et performance cognitive

  110. Hindmarch I, et al. (1991). Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. International Clinical Psychopharmacology, 6(1), 31–43. PubMed · PMID 2071888
    DOI : 10.1097/00004850-199100610-00005

    Contenus utilisant cette ressource : vinpocétine

  111. Sublette ME, et al. (2011). Meta-analysis of the effects of EPA in clinical trials in depression. Journal of Clinical Psychiatry, 72(12), 1577–1584. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Nootropiques pour les femmes : cycle hormonal et performance cognitive

  112. Freeman MP, et al. (2006). Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. Journal of Clinical Psychiatry, 67(12), 1954–1967. PubMed · PMID 17194275
    DOI : 10.4088/jcp.v67n1217

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  113. Viola, H. et al. (1995). Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Medica, 61(3), 213–216. PubMed · PMID 7617761
    DOI : 10.1055/s-2006-958058

    Contenus utilisant cette ressource : Apigénine

  114. Subhan Z & Hindmarch I (1985). Psychopharmacological effects of vinpocetine in normal healthy volunteers. European Journal of Clinical Pharmacology, 28(5), 567–571. PubMed · PMID 3899677
    DOI : 10.1007/BF00544068

    Contenus utilisant cette ressource : vinpocétine

  115. Malykh, A.G., Sadaie, M.R. (2010). Piracetam and piracetam-like drugs: from basic science to novel clinical applications. Drugs, 70(3), 287–312. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Oxiracétam pramiracétam

  116. Sandor, P.S. et al. (2005). Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology, 64(4), 713–715. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Coenzyme Q10

  117. Moshiri E, et al. (2006). Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine, 13(9–10), 607–611. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Extrait de Safran

  118. Wankhede S, et al. (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition, 12, 43. PubMed · PMID 26609282
    DOI : 10.1186/s12970-015-0104-9

    Contenus utilisant cette ressource : ashwagandha

  119. Nagano M, et al. (2010). Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical Research, 31(4), 231–237. PubMed · PMID 20834180
    DOI : 10.2220/biomedres.31.231

    Contenus utilisant cette ressource : Crinière de Lion

  120. Cryan, J.F. et al. (2019). The Microbiota-Gut-Brain Axis. Physiological Reviews, 99(4), 1877–2013. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Axe intestin-cerveau et performance cognitive

  121. Avgerinos KI, et al. (2018). Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials. Experimental Gerontology, 108, 166–173. PubMed · PMID 29704637
    DOI : 10.1016/j.exger.2018.04.013

    Contenus utilisant cette ressource : Créatine

  122. Sonnenburg, J.L. & Bäckhed, F. (2016). Diet–microbiota interactions as moderators of human metabolism. Nature, 535, 56–64. PubMed · PMID 27383980
    DOI : 10.1038/nature18846

    Contenus utilisant cette ressource : Axe intestin-cerveau et performance cognitive

  123. Wurtman RJ, et al. (2010). Synergistic effects of choline and DHA on synaptic formation. Neurochemical Research, 35(12), 2107–2116. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Monophosphate d'uridine

  124. Mahoney CR, et al. (2007). Tyrosine supplementation mitigates working memory decrements during cold exposure. Physiology & Behavior, 92(4), 575–582. PubMed · PMID 17585971
    DOI : 10.1016/j.physbeh.2007.05.003

    Contenus utilisant cette ressource : N-Acétyl L-Tyrosine

  125. Hardman MI, et al. (2019). Phenibut withdrawal: a comprehensive literature review and illustrative case report. Bosnian Journal of Basic Medical Sciences. PubMed · PMID 30501608
    DOI : 10.17305/bjbms.2018.4008

    Contenus utilisant cette ressource : phénibut

  126. Hirsch KR, et al. (2017). Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation. Journal of Dietary Supplements, 14(1), 42–53. PubMed · PMID 27408987
    DOI : 10.1080/19390211.2016.1203386

    Contenus utilisant cette ressource : cordyceps

  127. Kondo DG, et al. (2011). Open-label uridine for treatment of depressed adolescents with bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 21(2), 171–175. PubMed · PMID 21486171
    DOI : 10.1089/cap.2010.0054

    Contenus utilisant cette ressource : Monophosphate d'uridine

  128. Sublette ME, et al. (2011). Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. Journal of Clinical Psychiatry, 72(12), 1577–1584. PubMed · PMID 21939614
    DOI : 10.4088/JCP.10m06634

    Contenus utilisant cette ressource : Suppléments naturels pour la dépression et l'anxiété : un guide basé sur des preuves

  129. Lopresti AL, et al. (2014). Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. Journal of Affective Disorders, 167, 368–375. PubMed · PMID 25046624
    DOI : 10.1016/j.jad.2014.06.001

    Contenus utilisant cette ressource : curcumine

  130. Firstova YY, et al. (2011). Studying specific nootropic activity of the peptide preparation noopept and phenotropil on a model of scopolamine-induced cognitive deficit in rats. Eksperimentalnaya i Klinicheskaya Farmakologiya, 74(4), 3–7. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Phénylpiracétam

  131. Wilsher, C.R. et al. (1987). Piracetam and dyslexia: effects on reading tests. Journal of Clinical Psychopharmacology, 7(4), 230–237. PubMed · PMID 3305591

    Contenus utilisant cette ressource : Piracétam

  132. Bradwejn, J. et al. (2000). A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. Journal of Clinical Psychopharmacology, 20(6), 680–684. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Centella asiatica (Gotu Kola)

  133. Grosso G, et al. (2014). Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxidative Medicine and Cellular Longevity, 2014, 313570. PubMed · PMID 24757497
    DOI : 10.1155/2014/313570

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  134. Turner EH, et al. (2006). Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacology & Therapeutics, 109(3), 325–338. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : 5-HTP

  135. Rucker R, et al. (2009). Potential physiological importance of pyrroloquinoline quinone. Alternative Medicine Review, 14(3), 268–277. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : PQQ (Pyrroloquinoline Quinone)

  136. Bliss TVP, Collingridge GL. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature, 361, 31–39. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Neuroplasticité : comment le cerveau se reconfigure-t-il ?

  137. Zhang Z, et al. (2008). A systematic review of the efficacy and safety of huperzine A in Alzheimer's disease. Clinical Neuropharmacology, 31(4), 219–233. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Huperzine A

  138. Dinan, T.G., Stanton, C., & Cryan, J.F. (2013). Psychobiotics: a novel class of psychotropic. Biological Psychiatry, 74(10), 720–726. PubMed · PMID 23759244
    DOI : 10.1016/j.biopsych.2013.05.001

    Contenus utilisant cette ressource : Axe intestin-cerveau et performance cognitive

  139. Shaffer JA, et al. (2014). Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosomatic Medicine, 76(3), 190–196. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Vitamine D3

  140. Murphree HB, et al. (1960). The pharmacology of certain drugs used as antidepressants. Annals of the New York Academy of Sciences, 80, 679–687. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : DMAE

  141. Salamone JD, Correa M. (2012). The mysterious motivational functions of mesolimbic dopamine. Neuron, 76(3), 470–485. PubMed · PMID 23141060
    DOI : 10.1016/j.neuron.2012.10.021

    Contenus utilisant cette ressource : Motivation avec le système dopaminergique et les nootropiques

  142. Fan J, et al. (2019). Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy. European Journal of Pharmacology. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Berbérine

  143. Wattanathorn, J. et al. (2008). Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica. Journal of Ethnopharmacology, 116(2), 325–332. PubMed · PMID 18191355
    DOI : 10.1016/j.jep.2007.11.038

    Contenus utilisant cette ressource : Centella asiatica (Gotu Kola)

  144. Lieu CA, et al. (2010). A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. Parkinsonism & Related Disorders, 16(7), 458–465. PubMed · PMID 20570206
    DOI : 10.1016/j.parkreldis.2010.04.015

    Contenus utilisant cette ressource : Mucuna Pruriens

  145. Das YT, et al. (2004). Safety of 5-hydroxy-L-tryptophan. Toxicology Letters, 150(1), 111–122. PubMed · PMID 15068828
    DOI : 10.1016/j.toxlet.2003.12.070

    Contenus utilisant cette ressource : 5-HTP

  146. Zvejniece L, et al. (2011). Investigation into stereoselective pharmacological activity of phenotropil. Basic & Clinical Pharmacology & Toxicology, 109(5), 407–412. PubMed · PMID 21689376
    DOI : 10.1111/j.1742-7843.2011.00742.x

    Contenus utilisant cette ressource : Phénylpiracétam

  147. Gudasheva, T.A. et al. (1997). The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine. European Journal of Drug Metabolism and Pharmacokinetics, 22(3), 245–252. PubMed · PMID 9358206
    DOI : 10.1007/BF03189814

    Contenus utilisant cette ressource : noopept

  148. Littarru, G.P., Tiano, L. (2007). Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Molecular Biotechnology, 37(1), 31–37. PubMed · PMID 17914161
    DOI : 10.1007/s12033-007-0052-y

    Contenus utilisant cette ressource : Coenzyme Q10

  149. Orhan, I.E. (2012). Centella asiatica (L.) Urban: From traditional medicine to modern medicine with neuroprotective potential. Evidence-Based Complementary and Alternative Medicine. PubMed · PMID 22666298
    DOI : 10.1155/2012/946259

    Contenus utilisant cette ressource : Centella asiatica (Gotu Kola)

  150. Montgomery SA, et al. (2003). Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. International Clinical Psychopharmacology, 18(2), 61–71. PubMed · PMID 12598816
    DOI : 10.1097/00004850-200303000-00001

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  151. Owen DR, et al. (2016). Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity. Drug and Alcohol Review, 35(5), 591–596. PubMed · PMID 26693960
    DOI : 10.1111/dar.12356

    Contenus utilisant cette ressource : phénibut

  152. Bkaily G, et al. (2020). Taurine and cardiac disease: State of the art and perspectives. Canadian Journal of Physiology and Pharmacology. PubMed · PMID 31560859
    DOI : 10.1139/cjpp-2019-0313

    Contenus utilisant cette ressource : taureau

  153. Grossman R. (2005). The role of dimethylaminoethanol in cosmetic dermatology. American Journal of Clinical Dermatology, 6(1), 39–47. PubMed · PMID 15675889
    DOI : 10.2165/00128071-200506010-00005

    Contenus utilisant cette ressource : DMAE

  154. Wang J, et al. (2013). Magnesium L-threonate prevents and restores memory deficits associated with neuropathic pain. Pain Physician, 16(5), E563. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Mg L-Thréonate

  155. Bannai M, Kawai N. (2012). New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. Journal of Pharmacological Sciences, 118(2), 145–148. PubMed · PMID 22293292
    DOI : 10.1254/jphs.11r04fm

    Contenus utilisant cette ressource : Meilleurs nootropiques pour améliorer la qualité du sommeil

  156. Battleday RM, Brem AK. (2015). Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review. European Neuropsychopharmacology, 25(11), 1865–1881. PubMed · PMID 26381811
    DOI : 10.1016/j.euroneuro.2015.07.028

    Contenus utilisant cette ressource : modafinil

  157. Mills KF, et al. (2016). Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metabolism, 24(6), 795–806. PubMed · PMID 28068222
    DOI : 10.1016/j.cmet.2016.09.013

    Contenus utilisant cette ressource : NMN Mitochondries et énergie cérébrale : l'origine de la fatigue cognitive Cerveau anti-âge : Protocole nootropique anti-âge

  158. Talbott SM, et al. (2013). Effect of Tongkat Ali on stress hormones and psychological mood state. Journal of the International Society of Sports Nutrition, 10, 28. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Stress chronique et cerveau : l'effet du cortisol sur les performances cognitives

  159. Nakamura K, Tanaka Y. (2001). Antidepressant-like effects of aniracetam in aged rats and its mode of action. Psychopharmacology, 158(2), 205–212. PubMed · PMID 11702095
    DOI : 10.1007/s002130100849

    Contenus utilisant cette ressource : aniracétam

  160. Pizzi M, et al. (1999). Aniracetam prevents apoptotic death of cerebral cortex neurons via mGluR1 antagonism. Brain Research, 845(2), 250–256. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : aniracétam

  161. Yin J, et al. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 57(5), 712–717. PubMed · PMID 18442638
    DOI : 10.1016/j.metabol.2008.01.013

    Contenus utilisant cette ressource : Berbérine

  162. Nobre AC, et al. (2008). L-Theanine, a natural constituent in tea, and its effect on mental state. Asia Pacific Journal of Clinical Nutrition, 17(S1), 167–168. PubMed · PMID 18296328

    Contenus utilisant cette ressource : L-Théanine

  163. Dmitriev VN. (2003). Sulbutiamine (Enerion) in the treatment of patients with psychoorganic syndrome developing after brain injuries of different types. Neuroscience and Behavioral Physiology, 33(8), 767–771. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Sulbutiamine

  164. Rawson ES, Venezia AC. (2011). Use of creatine in the elderly and evidence for effects on cognitive function in young and old. Amino Acids, 40(5), 1349–1362. PubMed · PMID 21394604
    DOI : 10.1007/s00726-011-0855-9

    Contenus utilisant cette ressource : Performance cérébrale des athlètes : viser le pic physique et mental ensemble

  165. Hypericum Depression Trial Study Group. (2002). Effect of Hypericum perforatum (St John's Wort) in major depressive disorder. JAMA, 287(14), 1807–1814. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Millepertuis

  166. Trauner G, et al. (2008). Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid. Planta Medica, 74(1), 19–24. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Valériane (Valeriana)

  167. Shevtsov VA, et al. (2003). A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine, 10(2-3), 95–105. PubMed · PMID 12725561
    DOI : 10.1078/094471103321659780

    Contenus utilisant cette ressource : rhodiola rosea

  168. Akhapkina VI & Akhapkin RV (2002). Effects of phenotropil on cognitive function and quality of life in patients with consequences of stroke and traumatic brain injury. Zhurnal Nevrologii i Psikhiatrii imeni Korsakova, 102, 45–48. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Phénylpiracétam

  169. Peth-Nui T, et al. (2012). Effects of 12-week Bacopa monnieri consumption on attention, cognitive processing, working memory, and functions of both cholinergic and monoaminergic systems in healthy elderly volunteers. Evidence-Based Complementary and Alternative Medicine. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Bacopa Monnieri

  170. Minzenberg MJ, Carter CS. (2008). Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology, 33(7), 1477–1502. PubMed · PMID 17712350
    DOI : 10.1038/sj.npp.1301534

    Contenus utilisant cette ressource : modafinil

  171. Stohs SJ. (2014). Safety and efficacy of shilajit (mumie, moomiyo). Phytotherapy Research, 28(4), 475–479. PubMed · PMID 23733436
    DOI : 10.1002/ptr.5018

    Contenus utilisant cette ressource : shilajit

  172. Witte AV, et al. (2014). Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. Journal of Neuroscience, 34(23), 7862–7870. PubMed · PMID 24899709
    DOI : 10.1523/JNEUROSCI.0385-14.2014

    Contenus utilisant cette ressource : resvératrol Cerveau anti-âge : Protocole nootropique anti-âge

  173. Bereczki D & Fekete I (2008). Vinpocetine for acute ischaemic stroke. Cochrane Database of Systematic Reviews, (1), CD000480. PubMed · PMID 18253980
    DOI : 10.1002/14651858.CD000480.pub2

    Contenus utilisant cette ressource : vinpocétine

  174. Stabler SP. (2013). Vitamin B12 deficiency. New England Journal of Medicine, 368(2), 149–160. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Vitamines et minéraux essentiels pour le cerveau : le coût cognitif de la carence

  175. Zangara A (2003). The psychopharmacology of huperzine A: an old drug newly discovered. Pharmacology Biochemistry and Behavior, 75(3), 675–686. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Huperzine A

  176. Langade D, et al. (2019). Efficacy and safety of Ashwagandha (Withania somnifera) root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus, 11(9), e5797. PubMed · PMID 31728244
    DOI : 10.7759/cureus.5797

    Contenus utilisant cette ressource : ashwagandha

  177. Earnest CP, et al. (2004). Effects of a commercial herbal-based formula on exercise performance in cyclists. Medicine and Science in Sports and Exercise, 36(3), 504–509. PubMed · PMID 15076794
    DOI : 10.1249/01.mss.0000125157.49280.af

    Contenus utilisant cette ressource : cordyceps

  178. Biswas TK, et al. (2010). Clinical evaluation of spermatogenic activity of processed Shilajit in oligospermia. Andrologia, 42(1), 48–56. PubMed · PMID 20078516
    DOI : 10.1111/j.1439-0272.2009.00956.x

    Contenus utilisant cette ressource : shilajit

  179. Wang R & Tang XC (2005). Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease. Neurosignals, 14(1–2), 71–82. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Huperzine A

  180. DeKosky ST, et al. (2008). Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA, 300(19), 2253–2262. PubMed · PMID 19017911
    DOI : 10.1001/jama.2008.683

    Contenus utilisant cette ressource : Ginkgo Biloba

  181. Cumin R, et al. (1982). Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents. Psychopharmacology, 78(2), 104–111. PubMed · PMID 6817363
    DOI : 10.1007/BF00432244

    Contenus utilisant cette ressource : aniracétam

  182. Tan MS, et al. (2015). Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. Journal of Alzheimer's Disease, 43(2), 589–603. PubMed · PMID 25114079
    DOI : 10.3233/JAD-140837

    Contenus utilisant cette ressource : Ginkgo Biloba

  183. Kennedy DO, Scholey AB. (2003). Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacology Biochemistry and Behavior, 75(3), 687–700. PubMed · PMID 12895687
    DOI : 10.1016/s0091-3057(03)00126-6

    Contenus utilisant cette ressource : Panax Ginseng

  184. Mori K, et al. (2009). Improving effects of Lion's Mane on mild cognitive impairment. Phytotherapy Research, 23(3), 367–372. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Piles nootropiques : 5 combinaisons prouvées Cerveau anti-âge : Protocole nootropique anti-âge

  185. Ziegenfuss T, et al. (2008). Acute supplementation with alpha-glycerylphosphorylcholine augments growth hormone response to, and peak force production during, resistance exercise. Journal of the International Society of Sports Nutrition, 5(Suppl 1), P15. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Alpha-GPC

  186. Ostrovskaya, R.U. et al. (2007). Noopept stimulates the expression of NGF and BDNF in rat hippocampus. Bulletin of Experimental Biology and Medicine, 146(3), 334–337. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : noopept

  187. Valikovics A (2007). Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions. Ideggyogy Sz, 60(7–8), 301–310. PubMed · PMID 17713111

    Contenus utilisant cette ressource : vinpocétine

  188. Kennedy DO, et al. (2004). Modulation of mood and cognitive performance following acute administration of Melissa officinalis (Lemon Balm). Psychosomatic Medicine, 66(4), 607–613. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Mélisse (Mélisse citronnelle)

  189. Amsterdam, J.D. et al. (2009). A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. Journal of Clinical Psychopharmacology, 29(4), 378–382. PubMed · PMID 19593179
    DOI : 10.1097/JCP.0b013e3181ac935c

    Contenus utilisant cette ressource : Apigénine

  190. Pelsman, A. et al. (2003). GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. International Journal of Developmental Neuroscience, 21(3), 117–124. PubMed · PMID 12711349
    DOI : 10.1016/s0736-5748(03)00031-5

    Contenus utilisant cette ressource : noopept

  191. Abbasi B, et al. (2012). The effect of magnesium supplementation on primary insomnia in elderly. Journal of Research in Medical Sciences, 17(12), 1161–1169. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Meilleurs nootropiques pour améliorer la qualité du sommeil

  192. Starks MA, et al. (2008). The effects of phosphatidylserine on endocrine response to moderate intensity exercise. Journal of the International Society of Sports Nutrition, 5, 11. PubMed · PMID 18662395
    DOI : 10.1186/1550-2783-5-11

    Contenus utilisant cette ressource : Phosphatidylsérine

  193. Müller WE. (2003). Current St. John's Wort research from mode of action to clinical efficacy. Pharmacological Research, 47(2), 101–109. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Millepertuis

  194. Babb SM, et al. (2002). Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study. Psychopharmacology, 161(3), 248–254. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Monophosphate d'uridine

  195. Shukla KK, et al. (2010). Mucuna pruriens improves male fertility by its action on the hypothalamus-pituitary-gonadal axis. Fertility and Sterility, 92(6), 1934–1940. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Mucuna Pruriens

  196. Jakaria M, et al. (2019). Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms. Redox Biology, 24, 101223. PubMed · PMID 31141786
    DOI : 10.1016/j.redox.2019.101223

    Contenus utilisant cette ressource : taureau

  197. De Jesus Moreno Moreno M. (2003). Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clinical Therapeutics, 25(1), 178–193. PubMed · PMID 12637119
    DOI : 10.1016/s0149-2918(03)90023-3

    Contenus utilisant cette ressource : Alpha-GPC

  198. Scholey A, et al. (2014). Anti-stress effects of lemon balm-containing foods. Nutrients, 6(11), 4805–4821. PubMed · PMID 25360512
    DOI : 10.3390/nu6114805

    Contenus utilisant cette ressource : Mélisse (Mélisse citronnelle)

  199. Lapin I. (2001). Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug. CNS Drug Reviews, 7(4), 471–481. PubMed · PMID 11830761
    DOI : 10.1111/j.1527-3458.2001.tb00211.x

    Contenus utilisant cette ressource : phénibut

  200. Hidese S, et al. (2019). Effects of L-Theanine administration on stress-related symptoms and cognitive functions. Nutrients, 11(10), 2362. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Meilleurs nootropiques pour améliorer la qualité du sommeil

  201. Winblad, B. (2005). Piracetam: A review of pharmacological properties and clinical uses. CNS Drug Reviews, 11(2), 169–182. PubMed · PMID 16007238
    DOI : 10.1111/j.1527-3458.2005.tb00268.x

    Contenus utilisant cette ressource : Piracétam

  202. Stough C, et al. (2001). The chronic effects of an extract of Bacopa monniera on cognitive function in healthy human subjects. Psychopharmacology, 156(4), 481–484. PubMed · PMID 11498727
    DOI : 10.1007/s002130100815

    Contenus utilisant cette ressource : Piles nootropiques : 5 combinaisons prouvées

  203. Spasov AA, et al. (2000). A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5. Phytomedicine, 7(2), 85–89. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Performance cérébrale des athlètes : viser le pic physique et mental ensemble

  204. Swardfager W, et al. (2013). Potential roles of zinc in the pathophysiology and treatment of major depressive disorder. Neuroscience and Biobehavioral Reviews, 37(5), 911–929. PubMed · PMID 23567517
    DOI : 10.1016/j.neubiorev.2013.03.018

    Contenus utilisant cette ressource : Vitamines et minéraux essentiels pour le cerveau : le coût cognitif de la carence

  205. Tiev KP, et al. (1999). Treatment of chronic postinfectious fatigue: randomized double-blind study of two doses of sulbutiamine (400–600 mg/day) versus placebo. La Revue de médecine interne, 20(10), 912–918. PubMed · PMID 10573727
    DOI : 10.1016/s0248-8663(00)80096-x

    Contenus utilisant cette ressource : Sulbutiamine

  206. Bent S, et al. (2006). Valerian for sleep: a systematic review and meta-analysis. American Journal of Medicine, 119(12), 1005–1012. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Valériane (Valeriana)

  207. Herxheimer A, Petrie KJ. (2002). Melatonin for the prevention and treatment of jet lag. Cochrane Database of Systematic Reviews, (2), CD001520. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : mélatonine

  208. Fernández-San-Martín MI, et al. (2010). Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Medicine, 11(6), 505–511. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Valériane (Valeriana)

  209. Spasov AA, et al. (2000). A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine, 7(2), 85–89. PubMed · PMID 10839209
    DOI : 10.1016/S0944-7113(00)80078-1

    Contenus utilisant cette ressource : rhodiola rosea

  210. Chandrasekhar K, et al. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of KSM-66 ashwagandha. Indian Journal of Psychological Medicine, 34(3), 255–262. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Stress chronique et cerveau : l'effet du cortisol sur les performances cognitives

  211. Ostrovskaya, R.U. et al. (2012). Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation. Journal of Biomedical Science, 19(1), 74. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : noopept

  212. Owen, G.N. et al. (2008). The combined effects of L-Theanine and caffeine on cognitive performance and mood. Nutritional Neuroscience, 11(4), 193–198. PubMed · PMID 18681988
    DOI : 10.1179/147683008X301513

    Contenus utilisant cette ressource : Caféine et L-Théanine : le duo nootropique le plus éprouvé

  213. Kemeny V, et al. (2005). Vinpocetine increases cerebral blood flow and attenuates cognitive decline in patients with chronic cerebrovascular disease. Clinical Drug Investigation, 25(8), 525–534. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : vinpocétine

  214. Crook TH, et al. (1991). Effects of phosphatidylserine in age-associated memory impairment. Neurology, 41(5), 644–649. PubMed · PMID 2027477
    DOI : 10.1212/wnl.41.5.644

    Contenus utilisant cette ressource : Phosphatidylsérine

  215. Benton D & Donohoe R (2011). The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivores. British Journal of Nutrition, 105(7), 1100–1105. PubMed · PMID 21118604
    DOI : 10.1017/S0007114510004733

    Contenus utilisant cette ressource : Créatine

  216. LaRowe SD, et al. (2006). Is cocaine desire reduced by N-acetylcysteine? American Journal of Psychiatry, 163(6), 1115–1117. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  217. Ishaque S, et al. (2012). Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complementary and Alternative Medicine, 12, 70. PubMed · PMID 22643043
    DOI : 10.1186/1472-6882-12-70

    Contenus utilisant cette ressource : rhodiola rosea

  218. Secades JJ. (2011). Citicoline: pharmacological and clinical review, 2010 update. Revista de Neurología, 52(Suppl 2), S1–S62. PubMed · PMID 21432836

    Contenus utilisant cette ressource : CDP-Choline

  219. Akhondzadeh S, et al. (2004). Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial. BMC Complementary and Alternative Medicine, 4, 12. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Extrait de Safran

  220. Jongkees BJ, et al. (2015). Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands. Journal of Psychiatric Research, 70, 50–57. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Motivation avec le système dopaminergique et les nootropiques

  221. Ito I, et al. (1990). Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. Journal of Physiology, 424, 533–543. PubMed · PMID 1975272
    DOI : 10.1113/jphysiol.1990.sp018081

    Contenus utilisant cette ressource : aniracétam

  222. Shoba G, et al. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica, 64(4), 353–356. PubMed · PMID 9619120
    DOI : 10.1055/s-2006-957450

    Contenus utilisant cette ressource : curcumine

  223. Su KP, et al. (2003). Omega-3 fatty acids in major depressive disorder: a preliminary double-blind, placebo-controlled trial. European Neuropsychopharmacology, 13(4), 267–271. PubMed · PMID 12888186
    DOI : 10.1016/s0924-977x(03)00032-4

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  224. Linde K, et al. (2008). St John's Wort for major depression. Cochrane Database of Systematic Reviews, (4). Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Suppléments naturels pour la dépression et l'anxiété : un guide basé sur des preuves

  225. Lai PL, et al. (2013). Neurotrophic properties of the Lion's mane medicinal mushroom, Hericium erinaceus. Evidence-Based Complementary and Alternative Medicine. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Crinière de Lion

  226. Romanova, G.A. et al. (2001). Nootropic and neuroprotective effects of GVS-111 (noopept) at experimental ischemia. Bulletin of Experimental Biology and Medicine, 132(6), 1245–1247. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : noopept

  227. Hamzah S, Yusof A. (2003). The ergogenic effects of Eurycoma longifolia Jack. British Journal of Sports Medicine, 37(5), 464–470. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Tongkat Ali

  228. Shaw K, Turner J, Del Mar C. (2002). Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database of Systematic Reviews, (1), CD003198. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : 5-HTP

  229. Pratte MA, et al. (2014). An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). Journal of Alternative and Complementary Medicine, 20(12), 901–908. PubMed · PMID 25405876
    DOI : 10.1089/acm.2014.0177

    Contenus utilisant cette ressource : ashwagandha

  230. Koetter U, et al. (2007). A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination. Phytotherapy Research, 21(9), 847–851. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Valériane (Valeriana)

  231. Raut AA, et al. (2012). Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteers. Journal of Ayurveda and Integrative Medicine, 3(3), 111–114. PubMed · PMID 23125505
    DOI : 10.4103/0975-9476.100168

    Contenus utilisant cette ressource : ashwagandha

  232. Bianchetti A, et al. (2003). Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors. Current Medical Research and Opinion, 19(4), 350–353. PubMed · PMID 12841930
    DOI : 10.1185/030079903125001776

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  233. Müller U, et al. (2004). Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology, 64, 490–495. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : modafinil

  234. Shurtleff D, et al. (1994). Tyrosine reverses a cold-induced working memory deficit in humans. Pharmacology Biochemistry and Behavior, 47(4), 935–941. PubMed · PMID 8029265
    DOI : 10.1016/0091-3057(94)90299-2

    Contenus utilisant cette ressource : L-Tyrosine

  235. Alaimo JT, et al. (2020). Thiamine supplementation and cognitive performance: a review of the evidence. Journal of Clinical Nutritional Science, 5(1), 1–9. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Sulbutiamine

  236. Neznamov, G.G. & Teleshova, E.S. (2009). Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin. Neuroscience and Behavioral Physiology, 39(3), 311–321. PubMed · PMID 19234797
    DOI : 10.1007/s11055-009-9128-4

    Contenus utilisant cette ressource : noopept

  237. Sanmukhani J, et al. (2014). Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytotherapy Research, 28(4), 579–585. PubMed · PMID 23832433
    DOI : 10.1002/ptr.5025

    Contenus utilisant cette ressource : curcumine

  238. Fredholm, B.B. et al. (1999). Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews, 51(1), 83–133. PubMed · PMID 10049999

    Contenus utilisant cette ressource : Cyclage des nootropiques : comment éviter la tolérance ?

  239. Xu SS, et al. (1995). Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease. Zhongguo Yao Li Xue Bao, 16(5), 391–395. PubMed · PMID 8701750

    Contenus utilisant cette ressource : Huperzine A

  240. Borrelli F, Izzo AA. (2009). Herb–drug interactions with St John's Wort (Hypericum perforatum). AAPS Journal, 11(4), 710–727. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Millepertuis

  241. Berk M, et al. (2013). N-acetyl cysteine as a glutathione precursor for schizophrenia - a double-blind, randomized, placebo-controlled trial. Biological Psychiatry, 64(5), 361–368. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  242. Neri DF, et al. (1995). The effects of tyrosine on cognitive performance during extended wakefulness. Aviation, Space, and Environmental Medicine, 66(4), 313–319. PubMed · PMID 7794222

    Contenus utilisant cette ressource : N-Acétyl L-Tyrosine L-Tyrosine

  243. Brzezinski A, et al. (2005). Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews, 9(1), 41–50. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : mélatonine Meilleurs nootropiques pour améliorer la qualité du sommeil

  244. Itil, T.M. et al. (1986). The effects of oxiracetam in patients with organic brain syndrome. Drug Development Research, 9(1), 41–53. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Oxiracétam

  245. Mondadori, C. et al. (1992). Pramiracetam: a better memory enhancer than piracetam? Psychopharmacology, 106(Suppl), S130–S132. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : pramiracétam

  246. Kawagishi H, et al. (1994). Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Letters, 35(10), 1569–1572. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Crinière de Lion

  247. Mattson MP, et al. (2018). Mitochondria in neuroplasticity and neurological disorders. Neuron, 60(5), 748–766. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Mitochondries et énergie cérébrale : l'origine de la fatigue cognitive

  248. Kennedy DO, et al. (2010). Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans. American Journal of Clinical Nutrition, 91(6), 1590–1597. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : resvératrol

  249. Kimura K, et al. (2007). L-Theanine reduces psychological and physiological stress responses. Biological Psychology, 74(1), 39–45. PubMed · PMID 16930802
    DOI : 10.1016/j.biopsycho.2006.06.006

    Contenus utilisant cette ressource : L-Théanine

  250. Singh P, et al. (2023). Taurine deficiency as a driver of aging. Science, 380(6649), eabn9257. PubMed · PMID 37289866
    DOI : 10.1126/science.abn9257

    Contenus utilisant cette ressource : taureau

  251. Dolan E, et al. (2019). A systematic analysis of creatine's ergogenic, performance, and safety profiles. Nutrients, 11(12), 2924. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Créatine

  252. Bhatta S, et al. (2016). Shilajit combined with coenzyme Q10 supplementation improves mitochondrial function in aged animals. Journal of Medicinal Food, 19(7), 670–678. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : shilajit

  253. Ricci, S. et al. (2012). Piracetam for acute ischaemic stroke. Cochrane Database of Systematic Reviews, Issue 9. PubMed · PMID 22972044
    DOI : 10.1002/14651858.CD000419.pub3

    Contenus utilisant cette ressource : Piracétam

  254. Chen S, et al. (2010). Cordyceps sinensis and its fractions stimulate MA-10 mouse Leydig tumor cell steroidogenesis. Journal of Andrology, 31(2), 246–249. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : cordyceps

  255. Panossian A, Wikman G. (2010). Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress-Protective Activity. Pharmaceuticals, 3(1), 188–224. PubMed · PMID 27713248
    DOI : 10.3390/ph3010188

    Contenus utilisant cette ressource : rhodiola rosea

  256. Jia-Shi Z, et al. (2008). CordyMax Cs-4 improves steady-state bioenergy status in mouse liver. Journal of Alternative and Complementary Medicine, 14(3), 289–296. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : cordyceps

  257. Olsson EM, et al. (2009). A randomised, double-blind trial of Rhodiola rosea extract SHR-5 in fatigue. Planta Medica, 75(2), 105–112. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Motivation avec le système dopaminergique et les nootropiques

  258. Holick MF. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266–281. Rechercher PubMed (correspondance non vérifiée)

    Contenus utilisant cette ressource : Vitamine D3 Vitamines et minéraux essentiels pour le cerveau : le coût cognitif de la carence